Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.
Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.
J Glob Antimicrob Resist. 2021 Mar;24:260-265. doi: 10.1016/j.jgar.2021.01.003. Epub 2021 Jan 18.
Antimicrobial stewardship (AMS) in resource-limited settings lacks models that can be readily adapted to their settings. Here we discuss the impact of a combined strategy of AMS and monitoring of infection control practices in a tertiary-care centre of a developing country.
This study was undertaken in the surgical unit of a tertiary-care hospital over an 8-month period. In the first 2 months (baseline phase), prospective audit and feedback alone was undertaken, while in the next 6 months (intervention phase) this was supplemented with strategies such as antimicrobial timeout, correction of doses and bundle approach for prevention of hospital-acquired infections.
A total of 337 patients were included (94 in the baseline phase and 243 in the intervention phase). There was a decrease in days of therapy per 1000 patient-days (1000PD) (1112.3 days vs. 1048.6 days), length of therapy per 1000PD (956 days vs. 936.3 days) and defined daily doses (DDD) per 1000PD for most antimicrobials. A decrease in double cover for Gram-negative infections (9.6% vs. 2.9%) but an increase in double anaerobic cover (4.2% vs. 7.4%) was observed. There was a decrease in the incidence of ventilator-associated pneumonia per 1000 ventilator-days in the intervention phase (46.4 vs. 35.4), whereas central line-associated bloodstream infections per 1000 central line-days remained the same (14.7 vs. 14.8).
This study shows that implementation of routine AMS activities with monitoring of infection control practices can help decrease overall antimicrobial use. With furtherance of measures to control infection, antimicrobial use may be further curtailed.
在资源有限的环境中,抗菌药物管理(AMS)缺乏可以轻易适应该环境的模式。在这里,我们讨论了在一个发展中国家的三级保健中心,将 AMS 与感染控制措施监测相结合的策略的影响。
这项研究在一家三级医院的外科病房进行,历时 8 个月。在前 2 个月(基线阶段),仅进行前瞻性审核和反馈,而在后 6 个月(干预阶段),则补充了抗菌药物暂停、剂量纠正和预防医院获得性感染的捆绑方法等策略。
共纳入 337 例患者(基线阶段 94 例,干预阶段 243 例)。每 1000 个患者日的治疗天数(1000PD)(1112.3 天比 1048.6 天)、每 1000PD 的治疗时间(956 天比 936.3 天)和每 1000PD 的定义日剂量(DDD)均有所减少。革兰氏阴性感染的双重覆盖减少(9.6%比 2.9%),但双重厌氧菌覆盖增加(4.2%比 7.4%)。干预阶段每 1000 个通气日的呼吸机相关性肺炎发生率下降(46.4 比 35.4),而每 1000 个中央静脉导管日的中心静脉相关血流感染发生率保持不变(14.7 比 14.8)。
本研究表明,实施常规 AMS 活动并监测感染控制措施有助于减少总体抗菌药物使用。随着控制感染措施的进一步推进,抗菌药物的使用可能会进一步减少。